What is the role of iron deficiency in mood changes and how should it be evaluated and treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Deficiency and Mood: Clinical Impact and Management

Iron deficiency, even without anemia, significantly impairs mood, causing symptoms including depression, anxiety, irritability, fatigue, and cognitive dysfunction, and should be actively identified and treated to improve quality of life.

The Role of Iron in Mood Regulation

Iron is essential for neurotransmitter synthesis (including serotonin, dopamine, and norepinephrine), energy metabolism in the brain, and myelin formation 1. When iron stores are depleted, these critical neurological functions become impaired, directly affecting emotional regulation and mental health.

Specific Mood-Related Manifestations

Iron deficiency causes several psychiatric and behavioral symptoms:

  • Depression and anxiety: Recent meta-analysis demonstrates that iron supplementation in non-anemic individuals improves anxiety symptoms (effect size 0.34) and depression (effect size 0.93 in pre-post studies) 2
  • Irritability and mood instability: Commonly reported in both children and adults with iron deficiency 3
  • Cognitive fog and impaired concentration: Affects work capacity and daily functioning 4, 3
  • Fatigue: One of the most prominent symptoms, with supplementation showing improvement (effect size 0.34-1.01) 2
  • Restless leg syndrome: Frequently associated with iron deficiency 5, 6

In children and adolescents, iron deficiency causes developmental delays, decreased motor activity, reduced social interaction, and attention deficits that may persist even after treatment if not corrected early 4.

Evaluation Strategy

Laboratory Assessment

Measure serum ferritin as the primary screening test, using a threshold of 45 μg/L to diagnose iron deficiency 7. However, recognize that:

  • In inflammatory conditions, ferritin may be falsely elevated; consider iron deficiency if ferritin is <100 μg/L with inflammation 7
  • Confirm with transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin if ferritin is equivocal 7
  • Complete blood count to assess for anemia (hemoglobin, MCV) 8, 9

Identifying the Underlying Cause

After confirming iron deficiency, systematically evaluate:

  1. Dietary intake: Assess adequacy of iron-rich foods
  2. Menstrual blood loss: In premenopausal women, heavy menstrual bleeding is the most common cause 10
  3. Gastrointestinal evaluation (if indicated):
    • Test for Helicobacter pylori and eradicate if present 8
    • Screen for celiac disease with anti-endomysial antibodies (and IgA level) 10
    • Consider bidirectional endoscopy in patients >45 years or with GI symptoms 10, 9

Treatment Approach

Oral Iron Supplementation

Start with ferrous sulfate 200 mg once daily (or every other day if not tolerated), as lower doses may be equally effective with better tolerability 9, 8.

Key points:

  • Ferrous fumarate and ferrous gluconate are equally effective alternatives 8, 10
  • Continue treatment for 3 months after hemoglobin normalizes to replenish iron stores 8, 9, 8
  • Expect hemoglobin to rise by 2 g/dL after 3-4 weeks 10
  • Ascorbic acid (250-500 mg) may enhance absorption but evidence is limited 8

Intravenous Iron

Use intravenous iron when oral iron is not tolerated, ineffective, or in conditions with impaired absorption 8, 9, 8. Specific indications include:

  • Inflammatory bowel disease with active inflammation 7
  • Malabsorption syndromes (celiac disease, post-gastric surgery) 11, 7
  • Intolerance to multiple oral formulations 8, 9
  • Ongoing blood loss exceeding oral replacement capacity 11, 7

Available preparations include iron sucrose, ferric carboxymaltose, and iron dextran, with varying infusion times and costs 8.

Monitoring Response

Reassess hemoglobin and symptoms at 4 weeks 9. If no response:

  • Evaluate for non-compliance (often due to GI side effects)
  • Consider ongoing blood loss
  • Assess for malabsorption
  • Consider switching to intravenous iron 10

After successful treatment, monitor blood counts every 3-6 months initially to detect recurrence 9, 12.

Impact of Treatment on Mood

The evidence strongly supports that correcting iron deficiency improves mood outcomes:

  • Improvements in iron status (transferrin saturation, hemoglobin) correlate with reduced anger/hostility and improved appetite 13
  • Supplementation reduces anxiety, depression, and fatigue even in non-anemic individuals 2
  • Physical well-being and cognitive function improve with iron repletion 2

These mood improvements occur regardless of protein source in the diet, indicating that iron status itself—not dietary composition—drives the benefit 13.

Critical Clinical Pitfalls

  1. Don't overlook iron deficiency without anemia: Mood symptoms can occur before anemia develops 12, 2, 3
  2. Don't assume menstrual bleeding explains all cases in young women: Consider GI pathology if symptoms persist despite treatment 10
  3. Don't use fecal occult blood testing: It is insensitive and non-specific for investigating iron deficiency 8
  4. Don't stop treatment when hemoglobin normalizes: Continue for 3 months to replenish stores 8, 9, 8
  5. Recognize that iron deficiency affects multiple neurotransmitter systems: The mood effects are mechanistically linked to impaired dopamine, serotonin, and norepinephrine synthesis 1, 14

References

Research

Iron and mechanisms of emotional behavior.

The Journal of nutritional biochemistry, 2014

Research

[Iron deficiency in elderly people: clinical presentation and management].

Geriatrie et psychologie neuropsychiatrie du vieillissement, 2014

Research

Prevalence of Risk of Iron Deficiency.

Canadian journal of pain = Revue canadienne de la douleur, 2026

Research

Iron dyshomeostasis in neuropsychiatric disorders.

Frontiers in psychiatry, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.